Clinical Trial Update: ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating valganciclovir for cytomegalovirus viraemia in advanced HIV disease is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Wits Health Consortium (Pty) Ltd | Conditions: Cytomegalovirus (CMV) Infection | Phase 2 | Status: NOT_YET_RECRUITING